BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15163131)

  • 1. Effects of hyperinsulinaemia on erythromycin-induced gallbladder and gastric motility in normal subjects.
    Cordoni MC; Distrutti E; Vermigli C; Marino C; Bottini P; Bosso R; Scionti L
    Diabetes Nutr Metab; 2004 Feb; 17(1):72-5. PubMed ID: 15163131
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
    Fiorucci S; Distrutti E; Gerli R; Morelli A
    Am J Gastroenterol; 1994 Apr; 89(4):550-5. PubMed ID: 8147358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration.
    Jones KL; Kong MF; Berry MK; Rayner CK; Adamson U; Horowitz M
    Am J Gastroenterol; 1999 Aug; 94(8):2074-9. PubMed ID: 10445530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
    Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
    J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.
    Fiorucci S; Distrutti E; Bassotti G; Gerli R; Chiucchiù S; Betti C; Santucci L; Morelli A
    Scand J Gastroenterol; 1994 Sep; 29(9):807-13. PubMed ID: 7824860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric emptying and prokinetics.
    Hegde R
    Intensive Care Med; 1997 Aug; 23(8):928. PubMed ID: 9310822
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of increased gastric motility effect of EM523].
    Shiba Y; Mizuki A; Inatomi N; Yamamoto O; Sato S
    J Smooth Muscle Res; 1995 Dec; 31(6):492-5. PubMed ID: 8867984
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin and motilin as gastrointestinal prokinetic agents.
    Asai T
    Eur J Anaesthesiol; 1997 Jan; 14(1):3-6. PubMed ID: 9049551
    [No Abstract]   [Full Text] [Related]  

  • 10. L-arginine/nitric oxide pathway modulates gastric motility and gallbladder emptying induced by erythromycin and liquid meal in humans.
    Fiorucci S; Distrutti E; Quintieri A; Sarpi L; Spirchez Z; Gulla N; Morelli A
    Dig Dis Sci; 1995 Jun; 40(6):1365-71. PubMed ID: 7781462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent.
    Weber FH; Richards RD; McCallum RW
    Am J Gastroenterol; 1993 Apr; 88(4):485-90. PubMed ID: 8470625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a Gluten-Containing Meal on Gastric Emptying and Gallbladder Contraction.
    Massironi S; Branchi F; Fraquelli M; Baccarin A; Somalvico F; Ferretti F; Conte D; Elli L
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30012987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans.
    Gielkens HA; Lam WF; Coenraad M; Frölich M; van Oostayen JA; Lamers CB; Masclee AA
    J Hepatol; 1998 Apr; 28(4):595-602. PubMed ID: 9566827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does chronic alcohol drinking modify digestive gastrobiliary motility?].
    Wedmann B; Pfaffenbach B; Wegener M
    Leber Magen Darm; 1996 Mar; 26(2):98-102. PubMed ID: 8684250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why use erythromycin to manage gastroparesis?
    King JE
    Nursing; 2007 Jun; 37(6):20. PubMed ID: 17538420
    [No Abstract]   [Full Text] [Related]  

  • 16. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders].
    Peeters TL
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles of pharmacotherapy].
    Wienbeck M; Barnert J
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():22-6; discussion 43. PubMed ID: 2162581
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 (insulin-dependent) diabetes mellitus and gastric emptying: role of blood glucose concentration and dopamine D2 receptors.
    Melga P; Mansi C
    Diabetes Nutr Metab; 2004 Feb; 17(1):62-5. PubMed ID: 15163128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contractile effect of erythromycin on the gallbladder].
    Fu D; Zhang Y; Wang Z
    Zhonghua Wai Ke Za Zhi; 1995 Dec; 33(12):757-9. PubMed ID: 8762558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.